Skip to main content

Advertisement

Log in

Defining Incidence and Risk Factors of Venous Thromboemolism after Hepatectomy

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

An Erratum to this article was published on 12 February 2014

Abstract

Background

The incidence of venous thromboembolism (VTE) among patients undergoing hepatic surgery is poorly defined, leading to varied use of VTE prophylaxis among surgeons. We sought to define the incidence of VTE after liver surgery and identify risk factors associated with VTE.

Methods

Incidence of VTE and associated risk factors within 90 days of hepatic resection between 2006 and 2012 at a major academic center was analyzed. Risk factors for VTE were identified using univariate and multivariate analyses.

Results

A total of 599 patients were included in the study cohort; 30 (5.0 %) had a prior history of VTE. The indications for surgery were malignant (90.8 %) and benign lesions (9.2 %). The majority of patients underwent a minor hepatectomy (<3 Couinaud segments; n = 402, 67.1 %) while 195 (32.6 %) patients underwent a major hepatectomy (≥3 Couinaud segments). Three hundred seven (51.3 %) patients were started on VTE chemoprophylaxis preoperatively with 407 (67.8 %) patients receiving VTE chemoprophylaxis within 24 h of surgery. Twenty-eight (4.7 %) patients developed VTE; 20 (3.3 %) had deep venous thrombosis (DVT), 11 (1.8 %) had pulmonary embolism (PE), and three (0.5 %) developed both DVT and PE. Among the VTE patients, 23 (82.1 %) had received VTE chemoprophylaxis. On multivariate analyses, history of VTE (odds ratio [OR] 4.51, 95 % confidence interval [CI] 1.81–17.22, P = 0.03), prolonged operative time (OR 1.17 per additional hour, 95 % CI 1.04–1.32, P = 0.009), and increased length of stay (LOS) (OR 1.07, 95 % CI 1.02–1.12, P = 0.01) were independent risk factors for VTE.

Conclusion

VTE within 90 days of hepatic resection is common, occurring in nearly one in 20 patients. Most VTE events occurred among patients who received current best practice prophylaxis for VTE. More aggressive strategies to identify and reduce the risk of VTE in patients at highest risk of VTE, including those with a history of VTE, extended operative time, and prolonged LOS, are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Collins, R., A. Scrimgeour, S. Yusuf and R. Peto, Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med, 1988. 318(18): p. 1162–73.

    Article  CAS  PubMed  Google Scholar 

  2. Mismetti, P., S. Laporte, J.Y. Darmon, et al., Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg, 2001. 88(7): p. 913–30.

    Article  CAS  PubMed  Google Scholar 

  3. Caprini, J.A., J.I. Arcelus, J.H. Hasty, et al., Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost, 1991. 17 Suppl 3: p. 304–12.

    PubMed  Google Scholar 

  4. Gould, M.K., D.A. Garcia, S.M. Wren, et al., Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012. 141(2 Suppl): p. e227S–77S.

    CAS  PubMed Central  PubMed  Google Scholar 

  5. Dindo, D., N. Demartines and P.A. Clavien, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 2004. 240(2): p. 205–13.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Mayo, S.C., A.D. Shore, H. Nathan, et al., Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford), 2011. 13(7): p. 473–82.

    Article  Google Scholar 

  7. Ho, Y.H., F. Seow-Choen, A. Leong, et al., Randomized, controlled trial of low molecular weight heparin vs. no deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients. Dis Colon Rectum, 1999. 42(2): p. 196–202; discussion 202–3.

    Article  CAS  PubMed  Google Scholar 

  8. De Martino, R.R., P.P. Goodney, E.L. Spangler, et al., Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg, 2012. 55(4): p. 1035–1040 e4.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Hyder, O., C. Pulitano, A. Firoozmand, et al., A risk model to predict 90-day mortality among patients undergoing hepatic resection. J Am Coll Surg, 2013. 216(6): p. 1049–56.

    Article  PubMed  Google Scholar 

  10. Sato, M., R. Tateishi, H. Yasunaga, et al., Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol, 2012. 47(10): p. 1125–33.

    Article  PubMed  Google Scholar 

  11. Bhayani, N.H., O. Hyder, W. Frederick, et al., Effect of metabolic syndrome on perioperative outcomes after liver surgery: a National Surgical Quality Improvement Program (NSQIP) analysis. Surgery, 2012. 152(2): p. 218–26.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Jarnagin, W.R., M. Gonen, Y. Fong, et al., Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg, 2002. 236(4): p. 397–406; discussion 406–7.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Turley, R.S., S.K. Reddy, C.K. Shortell, et al., Venous thromboembolism after hepatic resection: analysis of 5,706 patients. J Gastrointest Surg, 2012. 16(9): p. 1705–14.

    Article  PubMed  Google Scholar 

  14. Reddy, S.K., R.S. Turley, A.S. Barbas, et al., Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks? J Gastrointest Surg, 2011. 15(9): p. 1602–10.

    Article  PubMed  Google Scholar 

  15. Barton, J.S., G.M. Riha, J.A. Differding, et al., Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB (Oxford), 2013.

    Google Scholar 

  16. Cerutti, E., C. Stratta, R. Romagnoli, et al., Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl, 2004. 10(2): p. 289–94.

    Article  PubMed  Google Scholar 

  17. Senzolo, M., M.T. Sartori and T. Lisman, Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? HPB (Oxford), 2009. 11(6): p. 459–64.

    Article  Google Scholar 

  18. Salami, A., W. Qureshi, P. Kuriakose, et al. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review. Transplant Proc, 2013. 45(1): p. 315–9.

    Article  CAS  PubMed  Google Scholar 

  19. Aldawood, A., Y. Arabi, A. Aljumah, et al., The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thromb J, 2011. 9(1): p. 1.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Lesmana, C.R., S. Inggriani, L. Cahyadinata and L.A. Lesmana, Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition? Hepatol Int, 2010. 4(1): p. 433–8.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Dabbagh, O., A. Oza, S. Prakash, et al., Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest, 2010. 137(5): p. 1145–9.

    Article  PubMed  Google Scholar 

  22. Barclay, S.M., M.N. Jeffres, K. Nguyen and T. Nguyen, Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease. Pharmacotherapy, 2013. 33(4): p. 375–82.

    Article  PubMed  Google Scholar 

  23. Tzeng, C.W., M.H. Katz, J.B. Fleming, et al., Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford), 2012. 14(8): p. 506–13.

    Article  PubMed Central  Google Scholar 

  24. Merkow, R.P., K.Y. Bilimoria, M.D. McCarter, et al., Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg, 2011. 254(1): p. 131–7.

    Article  PubMed  Google Scholar 

  25. Morris-Stiff, G., A. White, D. Gomez, et al., Thrombotic complications following liver resection for colorectal metastases are preventable. HPB (Oxford), 2008. 10(5): p. 311–4.

    Article  CAS  Google Scholar 

  26. Hacker, R.I., G. Ritter, C. Nelson, et al., Subcutaneous heparin does not increase postoperative complications in neurosurgical patients: An institutional experience. J Crit Care, 2012. 27(3): p. 250–4.

    Article  CAS  PubMed  Google Scholar 

  27. Cohen, A.T., M.B. Wagner and M.S. Mohamed, Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis. Am J Surg, 1997. 174(1): p. 1–5.

    Article  CAS  PubMed  Google Scholar 

  28. McLeod, R.S., W.H. Geerts, K.W. Sniderman, et al., Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg, 2001. 233(3): p. 438–44.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. De, A., P. Roy, V.K. Garg and N.K. Pandey, Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. Blood Coagul Fibrinolysis, 2010. 21(1): p. 57–61.

    Article  CAS  PubMed  Google Scholar 

  30. Mita, K., H. Ito, R. Murabayashi, et al., Postoperative bleeding complications after gastric cancer surgery in patients receiving anticoagulation and/or antiplatelet agents. Ann Surg Oncol, 2012. 19(12): p. 3745–52.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Timothy M. Pawlik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ejaz, A., Spolverato, G., Kim, Y. et al. Defining Incidence and Risk Factors of Venous Thromboemolism after Hepatectomy. J Gastrointest Surg 18, 1116–1124 (2014). https://doi.org/10.1007/s11605-013-2432-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-013-2432-x

Keywords

Navigation